Surgery first vs chemotherapy first in early triple negative and HER2 positive breast cancer.
Phase 3
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/02/063118
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Histologically proved breast carcinoma
2.Triple negative(ER, PgR, HER2-neu) and HER2-neu positive (ER/PgR +/-)
3.T1-2 (excluding T1a), N0-1 (non-metastatic)
4. > 18 years < 65 years
5.ECOG 0-1
6.Written informed consent
7.Fit for surgery or chemotherapy
Exclusion Criteria
1.Pregnant, lactating women
2.Previous h/o breast or any other non-skin malignancy
3.Previous treatment for excision biopsy/other cancer.
4.History of allergy to Inj. Lignocaine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method